Sensyne Health (SENS)

Sector:

Health Care

Index:

FTSE AIM All-Share

45.00p
   
  • Change Today:
    -2.50p
  • 52 Week High: 187.50p
  • 52 Week Low: 39.50p
  • Currency: UK Pounds
  • Shares Issued: 128.57m
  • Volume: 25,831
  • Market Cap: £57.86m
  • RiskGrade: 446

Deal with Barclays    Trade now with Barclays Stockbrokers

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
81.56% above the market average81.56% above the market average81.56% above the market average81.56% above the market average81.56% above the market average
88.24% above the sector average88.24% above the sector average88.24% above the sector average88.24% above the sector average88.24% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
96.38% above the market average96.38% above the market average96.38% above the market average96.38% above the market average96.38% above the market average
92.31% above the sector average92.31% above the sector average92.31% above the sector average92.31% above the sector average92.31% above the sector average
Price Book Ratio
37.01% above the market average37.01% above the market average37.01% above the market average37.01% above the market average37.01% above the market average
81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
43.6% below the market average43.6% below the market average43.6% below the market average43.6% below the market average43.6% below the market average
21.95% below the sector average21.95% below the sector average21.95% below the sector average21.95% below the sector average21.95% below the sector average
Price Chg 3m
96.37% below the market average96.37% below the market average96.37% below the market average96.37% below the market average96.37% below the market average
95.12% below the sector average95.12% below the sector average95.12% below the sector average95.12% below the sector average95.12% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
5.1% below the market average5.1% below the market average5.1% below the market average5.1% below the market average5.1% below the market average
5% below the sector average5% below the sector average5% below the sector average5% below the sector average5% below the sector average
Momentum 20
43.83% below the market average43.83% below the market average43.83% below the market average43.83% below the market average43.83% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
98.67% below the market average98.67% below the market average98.67% below the market average98.67% below the market average98.67% below the market average
93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
89.55% below the market average89.55% below the market average89.55% below the market average89.55% below the market average89.55% below the market average
94.59% below the sector average94.59% below the sector average94.59% below the sector average94.59% below the sector average94.59% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
91.05% below the market average91.05% below the market average91.05% below the market average91.05% below the market average91.05% below the market average
93.94% below the sector average93.94% below the sector average93.94% below the sector average93.94% below the sector average93.94% below the sector average
Operating Profit Loss
89.36% below the market average89.36% below the market average89.36% below the market average89.36% below the market average89.36% below the market average
94.59% below the sector average94.59% below the sector average94.59% below the sector average94.59% below the sector average94.59% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
24.80% above the market average24.80% above the market average24.80% above the market average24.80% above the market average24.80% above the market average
29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average
Cash
59.71% above the market average59.71% above the market average59.71% above the market average59.71% above the market average59.71% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
23.88% above the market average23.88% above the market average23.88% above the market average23.88% above the market average23.88% above the market average
23.81% above the sector average23.81% above the sector average23.81% above the sector average23.81% above the sector average23.81% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Sensyne Health Market Data

Currency UK Pounds
Share Price 45.00p
Change Today -2.50p
% Change -5.26 %
52 Week High 187.50p
52 Week Low 39.50p
Volume 25,831
Shares Issued 128.57m
Market Cap £57.86m
RiskGrade 446

Sensyne Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.07% above the market average23.07% above the market average23.07% above the market average23.07% above the market average23.07% above the market average
61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average
Price Trend
68.29% below the market average68.29% below the market average68.29% below the market average68.29% below the market average68.29% below the market average
65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average
Income Not Available
Growth
14.99% above the market average14.99% above the market average14.99% above the market average14.99% above the market average14.99% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Sensyne Health Dividends

No dividends found

Trades for 24-Feb-2020

Time Volume / Share Price
16:02 1,500 @ 45.00p
16:02 7,500 @ 45.00p
14:40 1,976 @ 44.00p
14:36 3,593 @ 46.97p
14:18 2,113 @ 46.75p

Sensyne Health Key Personnel

CEO Paul Drayson
CFO Lorimer Headley

Top of Page